WASHINGTON, Aug. 21 /PRNewswire/ -- James J. Kelly, former president and CEO of Carl Zeiss, has been selected as the new president and CEO of the Food and Drug Law Institute (FDLI), the leading non-profit international organization of food, drug and medical device manufacturers, attorneys, regulators and consultants.
Before becoming president and CEO at Zeiss, the U.S. subsidiary of the German-based manufacturer of precision optics, Kelly held a variety of executive positions, including general manager for the Microscopy Group, general counsel and vice-president. Prior to Zeiss, Kelly served as vice- president, general counsel and head of human resources at Siemens Medical, one of the largest health care industry suppliers in the world.
A graduate of St. Joseph’s University and Villanova Law School, Kelly began his career in the general practice of law in New York City. He is a member of the New York State Bar and former vice-chairman of the German- American Chamber of Commerce in New York.
Kelly became president and CEO at FDLI August 14, 2006, succeeding Jerome A. Halperin, who stepped down after five years at the helm of the Washington, D.C.-based group.
“Kelly’s unique mix of legal, HR and general business experience within the medical device industry make him the right person at this important time in FDLI’s distinguished history to lead the organization to a new phase of strategic growth initiatives,” said Martin J. Levitas, chairman of the FDLI Board of Directors.
“I’m honored to be heading FDLI at a time when food and drug law and regulation is clearly a front-burner issue. I’m totally committed to expanding our membership and services so that more food and drug professionals can gain access to our world-class educational programs and publications,” said Kelly.
Founded in 1949, FDLI publishes the award-winning, peer-reviewed Food and Drug Law Journal, the bimonthly magazine Update, FDA Directory and dozens of books and publications for attorneys, regulatory affairs practitioners, scientists, health care professionals, government employees and marketers in the food and drug field.
Food and Drug Law Institute
CONTACT: Michael Levin-Epstein of the Food and Drug Law Institute,+1-202-371-1420
Web site: http://www.fdli.org//
